Table 5. Comparison of the potential metabolites in different groups by LSD post hoc analysis.
Metabolites | BA | NHS | Hyperbilirubinemia | Normal |
C5DC (µmol/l) | ||||
mean | 0.06a | 0.05 | 0.04 | 0.04 |
sd | 0.02 | 0.02 | 0.01 | 0.01 |
C2(µmol/l) | ||||
mean | 22.94b | 26.54b | 12.70 | 11.61 |
sd | 10.24 | 9.14 | 5.04 | 4.17 |
C3 (µmol/l) | ||||
mean | 2.68a | 3.68b | 1.17 | 1.49 |
sd | 1.64 | 1.67 | 0.66 | 1.00 |
C5 (µmol/l) | ||||
mean | 0.12a | 0.17b | 0.08 | 0.09 |
sd | 0.06 | 0.08 | 0.03 | 0.03 |
Cit/Arg | ||||
mean | 3.13b | 2.23b | 4.66 | 4.66 |
sd | 2.67 | 1.20 | 2.13 | 2.06 |
Gln (µmol/l) | ||||
mean | 9.50a | 12.33b | 5.41 | 7.10 |
sd | 4.44 | 3.93 | 5.61 | 5.54 |
Thr (µmol/l) | ||||
mean | 59.46 | 73.07c | 50.96 | 46.61 |
sd | 32.22 | 35.45 | 17.49 | 14.95 |
Glu (µmol/l) | ||||
mean | 204.62a | 171.21b | 279.32 | 282.56 |
sd | 83.53 | 52.35 | 55.11 | 52.00 |
Trp (µmol/l) | ||||
mean | 43.47b | 35.26b | 68.37 | 63.93 |
sd | 26.82 | 14.54 | 13.71 | 12.03 |
Have a significant difference at P<0.05 compared to NHS group, hyperbilirubinemia and normal group.
Have a significant difference at P<0.05 compared to hyperbilirubinemia and normal group.
Have a significant difference at P<0.05 compared to BA group, hyperbilirubinemia and normal group.